Treatment-specific prognostic performance of ELN 2022, ELN 2024, and Beat AML 2024: a real-world AML validation study. [PDF]
Kewan T +19 more
europepmc +1 more source
Prescription precision: Evaluating antimicrobial prescription practices in paediatric and neonatal inpatients. [PDF]
Theron C +5 more
europepmc +1 more source
Predicting cerebral palsy and 18-month neurodevelopmental outcome in infants with presumed hypoxic ischaemic encephalopathy: role of general movements assessment and early neurological examination. [PDF]
Kali GTJ +5 more
europepmc +1 more source
Widely used but weakly studied: a research agenda for Memory Cafés. [PDF]
Juckett LA +4 more
europepmc +1 more source
Noninvasive assessment of classic and high PPROM using cervicovaginal podocalyxin and nephrin: Findings from a prospective observational study. [PDF]
Kali Z +5 more
europepmc +1 more source
Physician Network Breadth in Medicare Advantage Plans Offering Part B Premium Givebacks.
Lavallee M +4 more
europepmc +1 more source
Correction to: Validation of the 4AT for assessing recovery from delirium in older hospital patients. [PDF]
europepmc +1 more source
Prevalence of risk phenotypes associated with <i>CYP2C9*2, *3,</i> and <i>VKORC1 c.-1639G>A</i> genetic polymorphisms in world populations: implications in clinical practice. [PDF]
Biswas M +6 more
europepmc +1 more source

